|
|
40
|
|
|
50421
|
|
|
ELOXATIN 100MG SOLN FOR INJ (SFA/COL) OXALIPLATIN
|
|
|
OXALIPLATIN
|
|
|
ELOXATIN
|
|
|
20ML
|
|
|
B
|
|
|
135.92
|
|
|
135.92
|
|
|
100MG
|
|
|
SOLUTION FOR
|
|
|
0
|
|
|
VIAL
|
|
|
SFA
|
|
|
SANOFI AVENTIS
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
Anti-Neoplastic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
No
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|